DOI:
10.1055/s-00000072
Seminars in Reproductive Medicine
LinksClose Window
References
Meyer AS, Miller MA, Gertler FB, Lauffenburger DA.
The receptor AXL diversifies EGFR signaling and limits the response to EGFR-targeted inhibitors in triple-negative breast cancer cells.
Sci Signal 2013;
6 (287) ra66
Access:
We do not assume any responsibility for the contents of the web pages of other providers.